Consideration with "Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector-p53"

Gene Ther. 2022 Jun;29(6):313-315. doi: 10.1038/s41434-021-00298-y.
No abstract available

Publication types

  • News

MeSH terms

  • Adenoviridae / genetics
  • Genes, p53
  • Genetic Therapy*
  • Genetic Vectors / genetics
  • Tumor Suppressor Protein p53* / genetics
  • Zalcitabine / analogs & derivatives

Substances

  • Tumor Suppressor Protein p53
  • 2',3'-dideoxy-5-methylcytidine
  • Zalcitabine